Anti-CD20/CD30 CAR-T cells

CAR-T cells targeting CD20 and CD30 · Shanghai First Song Biotechnology Co., LTD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD20/CD30 CAR-T cells, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma [EARLY_Phase 1]